ALEXSA Standardization for Clinical Use

ALEXSA 临床应用标准化

基本信息

  • 批准号:
    8705480
  • 负责人:
  • 金额:
    $ 33.32万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-03-01 至 2017-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): This STTR Phase II application is to finalize the one-of-its-kind Assessment of Liability and Exposure to Substance use and antisocial behavior(c) (ALEXSA(c)) for educator, pediatric, prevention and epidemiology uses. The ALEXSA system, first funded by a NIDA K-Award, acquires child-report (8- to 13-year-olds) data using an illustrated, computer format that is enjoyable and can be completed by illiterate youth. Nine risk domains (factor scores) and over 40 risk factor subscales canbeusedtomeasure liability to, and early forms of, problematic substance use (SU) and chronic behavior problems. The ALEXSA can be administered by child care professionals to groups of children or individuals. It is unique among child-report assessments in developmental appropriateness, breadth of characteristics measured, flexibility for tailored assessment, user-friendliness, and utility for research and intervention. The ALEXSA offers customers a format perceived by youth to have greater confidentiality than paper forms, automated data storage, and scores immediately upon completion (e.g., for screening and referral to intervention). Among ALEXSA's psychometric properties is a brief screen with an overall 85% predictive accuracy of SU one-year later among high-risk youth younger than 12 years old. This screen thus detects youth at high risk for substance use disorder long before its onset providing long-term opportunity for prevention. Phase I work developed a highly portable net book version and a PDA screen version of the ALEXSA. Phase II efforts will refine the ALEXSA using sophisticated methods and an extensive evaluation to enable in-depth clinical assessment of individuals (akin to IQ tests). ALEXSA scoring will be standardized to the U.S. general population. ALEXSA system products will be tailored to the needs of specific professions based on expert reviews. User's Manuals will be created. All products will be refined to be publish-quality. Collectively, this augmentation of the innovative ALEXSA research instrument into a tool that provides state-of-the-art assessment will assist professionalism meeting mandates for 6 million annual early intervention services and SU/SUD risk screenings by over 93,000 behavioral health professionals, over 150,000 primary care physicians and 41,000 school psychologists. The ALEXSA's innovative features, broad and evidence-based subscales and scores, and psychometric properties will permit it to fill gaps in several large niche markets and create barriers to potential competitors.
描述(由申请人提供):这份STTR II期申请是为了完成一份独一无二的物质使用和反社会行为的责任和暴露评估(ALEXSA(c)),用于教育工作者、儿科、预防和流行病学用途。ALEXSA系统最初由NIDA k奖资助,使用一种有趣的计算机格式获取儿童报告(8至13岁)数据,不识字的年轻人也可以完成。9个风险域(因子得分)和40多个风险因子子量表可以用来衡量对问题物质使用(SU)和慢性行为问题的责任和早期形式。ALEXSA可以由儿童护理专业人员对儿童群体或个人进行管理。在儿童报告评估中,它在发展适宜性、测量特征的广度、量身定制评估的灵活性、用户友好性以及研究和干预的实用性方面是独一无二的。ALEXSA为客户提供了一种被年轻人认为比纸质表格具有更高保密性的格式,自动数据存储,完成后立即评分(例如,用于筛选和转介干预)。在ALEXSA的心理测量特性中,有一个简短的筛选,在12岁以下的高风险青少年中,一年后SU的总体预测准确率为85%。因此,该筛检早在青少年出现物质使用障碍的高风险之前就能发现,为预防提供了长期机会。第一阶段的工作是开发ALEXSA的高度便携的上网本版本和PDA屏幕版本。第二阶段的工作将使用复杂的方法和广泛的评估来完善ALEXSA,以便对个人进行深入的临床评估(类似于智商测试)。ALEXSA评分标准将适用于美国普通人群。ALEXSA系统产品将根据专家审查的具体专业需求量身定制。将创建用户手册。所有产品都将经过改进,达到出版质量。总的来说,这个增广

项目成果

期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

MAUREEN D REYNOLDS其他文献

MAUREEN D REYNOLDS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('MAUREEN D REYNOLDS', 18)}}的其他基金

Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care
儿科初级保健中青少年的药物使用筛查和预防
  • 批准号:
    9069774
  • 财政年份:
    2014
  • 资助金额:
    $ 33.32万
  • 项目类别:
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care
儿科初级保健中青少年的药物使用筛查和预防
  • 批准号:
    9275952
  • 财政年份:
    2014
  • 资助金额:
    $ 33.32万
  • 项目类别:
Substance Use Screening and Prevention for Adolescents in Pediatric Primary Care
儿科初级保健中青少年的药物使用筛查和预防
  • 批准号:
    8611104
  • 财政年份:
    2014
  • 资助金额:
    $ 33.32万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了